The first drug proven to slow Alzheimer’s is on sale, but most U.S. patients will not be able to receive the treatment for several months. Experts say some reasons behind the slow debut for Leqembi, from Japanese drugmaker Eisai, are minimal insurance coverage and many health systems requiring a setup that takes a long time. The drug, … Read more
Side effects may include living longer. Rilmenidine — a drug commonly used to treat hypertension, or high blood pressure — has been found to slow the aging process and boost longevity, according to collaborative research from Harvard Medicine, the University of Liverpool and ETH Zürich. “With a global aging population, the benefits of delaying aging, … Read more
The party season is in full swing, but nothing kills that festive cheer quicker than a prolonged and painful hangover. However, a US pharmacist has shared the hangover “cure” she swears is “100 per cent effective” – and those who have put it to the test agree. Ari, a licenced doctor in LA, revealed she … Read more
CNN — Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid – but there’s a catch. Paxlovid can have dangerous interactions with some of the most common medications for cardiovascular disease, including certain statins and heart failure therapies, … Read more
CNN — Expectant mothers taking many common antidepressants need no longer worry the medication may harm their child’s future behavioral or cognitive neurodevelopment, according to a new study of over 145,000 women and their children across the United States followed for up to 14 years. “Results of previous studies on this topic have presented conflicting … Read more
CNN — Expectant mothers taking many common antidepressants need no longer worry the medication may harm their child’s future behavioral or cognitive neurodevelopment, according to a new study of over 145,000 women and their children across the United States followed for up to 14 years. “Results of previous studies on this topic have presented conflicting … Read more
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of experimental medicines, as the Associated Press has reported. The FDA approved the drug from Amylyx Pharmaceuticals based … Read more
CNN — Taking a daily multivitamin might be associated with improved brain function in older adults, a new study says, and the benefit appears to be greater for those with a history of cardiovascular disease. The findings did not surprise the researchers – rather, they were shocked, said Laura Baker, an author of the study … Read more
The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week without a staple of its normal decision-making process: data from a study showing whether the shots were safe and worked in humans. The shots, modified to target the latest versions of the omicron variant, won’t have finished testing in humans when the FDA … Read more